Evaluation of the NaviFUS System in Drug Resistant Epilepsy

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Epilepsy, Temporal LobeDrug Resistant Epilepsy
Interventions
DEVICE

NaviFUS System

NaviFUS System (Neuronavigation-Guided Focused Ultrasound System) is a new non-invasive device, which uses the neuronavigation principle to guide focused ultrasound (FUS) energy precisely delivering through the skull to selected brain tissues without surgery in real-time. In this clinical study, the NaviFUS System is intended to deliver low intensity FUS to generate neuromodulation effects on a predetermined treatment region (one or both of the hippocampi which are associated with seizure), for the treatment for drug-resistant temporal lobe epilepsy (TLE).

Trial Locations (1)

3004

RECRUITING

The Alfred, Melbourne

All Listed Sponsors
collaborator

Genovate Biotechnology Co., Ltd.,

INDUSTRY

collaborator

NaviFUS Corporation

INDUSTRY

lead

Genovate-NaviFUS (Australia) Pty Ltd.

INDUSTRY